Versor Investments’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Versor Investments’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-743,432	Closed	-$44.6M	–	423
2021 Q1	$44.6M	Buy	+743,432	New	+$26.9M	2.66%	20

Versor Investments's PAND Position: Q2 2021 in Review

Versor Investments sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 743,432 shares — an estimated $44.6M sold.

Versor Investments first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $44.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Versor Investments reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Versor Investments sold 743,432 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $44.6M.
Versor Investments first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Versor Investments's Pandion Therapeutics Inc. Common Stock position peaked at $44.6M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Versor Investments's 13F filing for Q2 2021, filed 27 Jul 2021.